危重意识障碍患者持续与常规脑电图的多中心随机试验
CERTA试验在瑞士4家三级医院纳入364例GCS≤11或FOUR≤12且近期无癫痫发作的危重成人,随机分至持续脑电图(cEEG)30–48小时组或2次常规脑电图(rEEG)组。cEEG增加发作间期特征和癫痫发作检出并更常调整抗癫痫治疗,但未改善结局。
核心结论
- 在危重意识障碍且近期无癫痫发作的成人中,cEEG较重复rEEG增加癫痫检出和治疗调整,但未改善6个月死亡率。
研究设计与样本
- CERTA为实用性多中心随机临床试验,2017–2018年在瑞士4家三级医院重症与中间监护单元开展,随访6个月。
- 纳入GCS≤11或FOUR≤12、近期无癫痫发作或癫痫持续状态的危重成人,共分析364例(33%女性,平均年龄63岁,SD 15)。
- 参与者1:1随机接受cEEG 30–48小时或2次rEEG(每次20分钟),按美国临床神经生理学会标准化指南判读。
- 结局由对干预不知情的访谈者评估,并获得独立医师紧急知情同意。
主要发现
- 按年龄、病前残疾、入院合并症、意识降低程度和基础诊断分层探索性比较未见显著效应修饰。
关键数值与推荐
- 入组标准包括GCS≤11或FOUR≤12,且近期无癫痫发作或癫痫持续状态。
临床怎么用
- 对危重意识障碍且近期无癫痫发作患者,cEEG可提高癫痫检出并指导抗癫痫治疗调整,但未显示生存获益。
- 在资源有限中心,重复rEEG可作为cEEG的可行替代方案。
局限性
- 样本量364例,作者指出需更大规模研究进一步验证。
- 研究在瑞士4家三级医院开展,外推性需谨慎。
- 探索性亚组比较未发现显著效应修饰,但亚组分析效力有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: In critically ill patients with altered consciousness, continuous electroencephalogram (cEEG) improves seizure detection, but is resource-consuming compared with routine EEG (rEEG). It is also uncertain whether cEEG has an effect on outcome. OBJECTIVE: To assess whether cEEG is associated with reduced mortality compared with rEEG. DESIGN, SETTING, AND PARTICIPANTS: The pragmatic multicenter Continuous EEG Randomized Trial in Adults (CERTA) was conducted between 2017 and 2018, with follow-up of 6 months. Outcomes were assessed by interviewers blinded to interventions.The study took place at 4 tertiary hospitals in Switzerland (intensive and intermediate care units). Depending on investigators' availability, we pragmatically recruited critically ill adults having Glasgow Coma Scale scores of 11 or less or Full Outline of Responsiveness score of 12 or less, without recent seizures or status epilepticus. They had cerebral (eg, brain trauma, cardiac arrest, hemorrhage, or stroke) or noncerebral conditions (eg, toxic-metabolic or unknown etiology), and EEG was requested as part of standard care. An independent physician provided emergency informed consent. INTERVENTIONS: Participants were randomized 1:1 to cEEG for 30 to 48 hours vs 2 rEEGs (20 minutes each), interpreted according to standardized American Clinical Neurophysiology Society guidelines. MAIN OUTCOMES AND MEASURES: Mortality at 6 months represented the primary outcome. Secondary outcomes included interictal and ictal features detection and change in therapy. RESULTS: We analyzed 364 patients (33% women; mean [SD] age, 63 [15] years). At 6 months, mortality was 89 of 182 in those with cEEG and 88 of 182 in those with rEEG (adjusted relative risk [RR], 1.02; 95% CI, 0.83-1.26; P = .85). Exploratory comparisons within subgroups stratifying patients according to age, premorbid disability, comorbidities on admission, deeper consciousness reduction, and underlying diagnoses revealed no significant effect modification. Continuous EEG was associated with increased detection of interictal features and seizures (adjusted RR, 1.26; 95% CI, 1.08-1.15; P = .004 and 3.37; 95% CI, 1.63-7.00; P = .001, respectively) and more frequent adaptations in antiseizure therapy (RR, 1.84; 95% CI, 1.12-3.00; P = .01). CONCLUSIONS AND RELEVANCE: This pragmatic trial shows that in critically ill adults with impaired consciousness and no recent seizure, cEEG leads to increased seizure detection and modification of antiseizure treatment but is not related to improved outcome compared with repeated rEEG. Pending larger studies, rEEG may represent a valid alternative to cEEG in centers with limited resources. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03129438.
引用
- Rossetti AO, Schindler K, Sutter R, et al. Continuous vs Routine Electroencephalogram in Critically Ill Adults With Altered Consciousness and No Recent Seizure: A Multicenter Randomized Clinical Trial. JAMA Neurol. 2020. PMID: 32716479. doi:10.1001/jamaneurol.2020.2264
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。